The Business Journals7d
Lantheus is on a buying spree. Its latest deal is worth up to $1B
Lantheus Holdings Inc. is adding to its portfolio yet again, acquiring a clinical-stage radiopharmaceutical company in a deal worth up to about $1 billion. Lantheus Holdings Inc. is adding to its ...
Lantheus To Acquire Evergreen Theragnostics; Reaffirms Guidance
Lantheus Holdings (LNTH) announced a definitive agreement to acquire Evergreen Theragnostics, Inc. in an all-cash transaction ...
pharmaphorum2y
Lantheus on POINT in radio-oncology with $2bn licensing deal
Lantheus is promising up to $1.8 billion in milestone payments to POINT if the two radiotherapeutics get FDA approval and meet commercial objectives, plus royalties on net sales.
Lantheus acquires Evergreen Theragnostics for $250M upfront payment
Lantheus (LNTH) announced a definitive agreement to acquire Evergreen Theragnostics in an all-cash transaction consisting of an upfront payment ...